According to Biocept 's latest financial reports the company's current revenue (TTM) is -$3.44 M. In 2022 the company made a revenue of $25.85 M a decrease over the years 2021 revenue that were of $61.24 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | -$3.44 M | -113.29% |
2022 | $25.85 M | -57.78% |
2021 | $61.24 M | 123.04% |
2020 | $27.46 M | 396.72% |
2019 | $5.52 M | 70.09% |
2018 | $3.25 M | -35.87% |
2017 | $5.06 M | 57.26% |
2016 | $3.22 M | 428.46% |
2015 | $0.6 M | 357.15% |
2014 | $0.13 M | -0.62% |
2013 | $0.13 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Veracyte VCYT | $0.36 B | -10,607.89% | ๐บ๐ธ USA |
Exact Sciences EXAS | $2.49 B | -72,852.21% | ๐บ๐ธ USA |
Myriad Genetics MYGN | $0.75 B | -22,020.84% | ๐บ๐ธ USA |